Lipid emulsion resuscitation for intractable calcium channel blocker toxicity in pediatric patients

Lipid emulsion resuscitation for intractable calcium channel blocker toxicity in pediatric patients

Saved in:

Bibliographic Details
Main Author:	Ju-Tae Sohn
Format:	Article
Language:	English
Published:	Hacettepe University Institute of Child Health 2024-07-01
Series:	The Turkish Journal of Pediatrics
Online Access:	https://turkjpediatr.org/article/view/4657
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Response to “Lipid emulsion resuscitation for intractable calcium channel blocker toxicity in pediatric patients”
by: Sinan Yavuz, et al.
Published: (2024-07-01)

Effect of intravenous lipid therapy in critically ill pediatric patients with calcium channel blocker toxicity
by: Sinan Yavuz, et al.
Published: (2024-02-01)

Direct effect of lipid emulsion treatment on local anesthetic systemic toxicity
by: Ju-Tae Sohn
Published: (2024-12-01)

Failure of intravenous lipid emulsion in treatment of cardiotoxicity caused by mixed overdose including dihydropyridine calcium channel blockers
by: Jović-Stošić Jasmina, et al.
Published: (2016-01-01)

Beta-blocker and calcium-channel blocker therapy in patients with cardiovascular pathologies during post-COVID period
by: A. G. Arutyunov, et al.
Published: (2022-01-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
by: M. A. Maksimova, et al.
Published: (2015-09-01)

Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
by: S. S. Yakushin, et al.
Published: (2024-02-01)

Lipid Emulsion for Local Anesthetic Systemic Toxicity
by: Sarah Ciechanowicz, et al.
Published: (2012-01-01)

High-Dose Insulin Euglycemic Therapy in Concomitant Beta-Blocker and Calcium Channel Blocker Overdose
by: Varun Roperia MD, et al.
Published: (2025-07-01)

Efficacy of insulin therapy in severe poisoning with calcium channel blockers
by: A. Yu. Simonova, et al.
Published: (2023-12-01)

THE EFFICACY AND SAFETY OF DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS IN HYPERTENSIVE PATIENTS: AMLODIPINE PLACE
by: M. V. Lebedeva, et al.
Published: (2015-09-01)

Intravenous calcium therapy in calcium channel blocker poisoning – A double-edged sword
by: Balaji Rajaram, et al.
Published: (2024-01-01)

Association of Calcium Channel Blocker Use With Intradialytic Hypotension in Maintenance Hemodialysis
by: Armida Lefranc Torres, et al.
Published: (2024-06-01)

Therapeutic Potential of Calcium Channel Blockers in Neuropsychiatric, Endocrine and Pain Disorders
by: Aarish Manzar, et al.
Published: (2025-07-01)

Calcium Channel Blockers: Key Medicine to Drive Global Hypertension Control
by: Andrew E. Moran, et al.
Published: (2025-07-01)

POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY
by: Yu. V. Lukina, et al.
Published: (2016-01-01)

TREATMENT OF ESSENTIAL HYPERTENSION WITH CALCIUM CHANNEL BLOCKERS: WHAT IS THE PLACE OF LERCANIDIPINE
by: Michel Burnier, et al.
Published: (2010-04-01)

A Modern View on the Treatment for Acute Calcium Channel Blocker Poisoning
by: A. Yu. Simonova, et al.
Published: (2024-09-01)

Interfacility Transfer for VA-ECMO in Beta Blocker and Calcium Channel Blocker Overdoses: A Report of Two Cases
by: Richard Fisher, et al.
Published: (2025-01-01)

L-type calcium channel blockers at therapeutic concentrations are not linked to CRAC channels and heart failure
by: Gary S. Bird, et al.
Published: (2025-12-01)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
by: Haotian Ma, et al.
Published: (2021-01-01)

Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism
by: Yuwen Sheng, et al.
Published: (2025-01-01)

HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
by: O. A. Kislyak, et al.
Published: (2017-07-01)

Сardioprotective agents with biaromatic structure. Part 1. Calcium channel blockers
by: G. V. Mokrov
Published: (2022-02-01)

Selection of antihypertensive therapy in elderly patients, combination therapy: thiazide-like diuretics and calcium channel blockers
by: z. M. Galeyeva, et al.
Published: (2018-12-01)

Efficacy of the calcium channel blocker amlodipine in the treatment of salt-sensitive hypertension in patients with different genetic status
by: N. V. Orlova, et al.
Published: (2023-11-01)

LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

WCN24-1937 RENOPROTECTIVE EFFECT OF 3RD GENERATION CALCIUM CHANNEL BLOCKERS
by: Joaquín Martinez Serventi, et al.
Published: (2024-04-01)

Relationship of CYP3A5 genetic polymorphism and efficacy of calcium channel blockers in the treatment of Chinese end-stage renal disease patients
by: ZHOU Jun, et al.
Published: (2016-01-01)

Neuroprotective effect of intravenous lipid emulsion after bupivacaine-induced cardiac toxicity
by: Mevlüt Doğukan, et al.
Published: (2025-07-01)

COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT)
by: O. V. Dralova, et al.
Published: (2016-01-01)

Computational Screening of Heterocyclic L-Type Calcium Channel Blockers for Potential Anti-Parkinson’s Activity
by: Thomas Kurian, et al.
Published: (2025-03-01)

Development of nifedipine isosteres: an integrated approach to the design, synthesis, and biological assessment of calcium channel blockers
by: Yasser M. Zohny, et al.
Published: (2025-05-01)

Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers
by: K. Makarounas-Kirchmann, et al.
Published: (2010-12-01)

Arterial hypertension treatment with a calcium channel blocker and an ACE inhibitor. Benefits of combination therapy
by: E. O. Taratukhin
Published: (2013-06-01)

Role of dihydropyridine calcium channel blockers in coronary bypass surgery using the radial artery graft
by: V. V. Zatolokin, et al.
Published: (2022-09-01)

Effects of T-type calcium channel blockers on renal function and aldosterone in patients with hypertension: a systematic review and meta-analysis.
by: Xue Li, et al.
Published: (2014-01-01)

ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION
by: N. A. Dzhaiani
Published: (2015-09-01)

FIXED COMBINATION OF THE CALCIUM CHANNEL BLOCKER LERCANIDIPINE AND ANGIOTENSIN CONVERTING ENZYME INHIBITOR ENALAPRIL: POSSIBILITY OF USAGE
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION
by: S. A. Boitsov, et al.
Published: (2016-01-01)